Fortis Healthcare Limited has informed the Exchange about Investor Presentation
FORTIS · price
▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.
Awaiting price reaction for this filing.
Fortis Healthcare reported Q3 FY26 consolidated revenue of INR 2,265 Cr, up 17.5% year-on-year, driven by strong hospital business growth. Operating EBITDA jumped 34.8% to INR 505 Cr, with margin expanding to 22.3% from 19.4% a year ago. Hospital business revenue grew 19.4% to INR 1,938 Cr with margins improving to 21.7% from 20.0%, supported by 14% growth in occupied beds. Diagnostics business Agilus saw revenue rise 8.3% to INR 371 Cr while its EBITDA margin surged to 23.1% from 14.4% last year. Net debt rose to INR 2,547 Cr (Net Debt/EBITDA at 1.24x vs 0.41x) due to the Agilus PE stake buyout and acquisitions of Shrimann Hospital and People Tree Hospital in Bengaluru (INR 430 Cr). Q3 reported PAT declined 22.4% due to a one-time INR 55.2 Cr impact from new Labour Codes, but 9-month PAT grew 27.6%.
Strong operational performance with double-digit revenue growth and meaningful margin expansion across both hospital and diagnostics segments signals healthy business momentum, though higher debt and one-time Labour Code charge in Q3 may temper short-term sentiment. The acquisitions and network expansion position Fortis for continued growth, supported by management's guidance of progressive improvement in diagnostics margins.